Literature DB >> 26574054

Potential diagnostic markers for disseminated intravascular coagulation of sepsis.

Toshiaki Iba1, Takashi Ito2, Ikuro Maruyama3, Bernd Jilma4, Thorsten Brenner5, Marcella C A Müller6, Nicole P Juffermans6, Jecko Thachil7.   

Abstract

Disseminated intravascular coagulation (DIC) is an acquired thrombo-haemorrhagic disorder which arises in clinical scenarios like sepsis, trauma and malignancies. The clinic-laboratory diagnosis of DIC is made in a patient who develops the combination of laboratory abnormalities in the appropriate clinical scenario. The most common laboratory parameters in this setting have been the clotting profile, platelet count, serum fibrinogen and fibrin degradation markers. These tests had the advantage that they could be performed easily and in most laboratories. However, with the better understanding of the pathophysiology of DIC, in recent years, more specific tests have been suggested to be useful in this setting. The newer tests can also prove to be useful in prognostication in DIC. In addition, they may provide assistance in the selection and monitoring of patients diagnosed with DIC.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antithrombin; Coagulation; Disseminated intravascular coagulation; High mobility group box protein; Histones; Protein C; Thrombomodulin; Von willebrand factor

Mesh:

Substances:

Year:  2015        PMID: 26574054     DOI: 10.1016/j.blre.2015.10.002

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  8 in total

1.  Type 1 interferon aggravates lipopolysaccharide-induced sepsis through upregulating Caspase-11 and Gasdermin D.

Authors:  Yan Wang; Xiaolei Zhang; Yujie Guo; Xiao Li; Guanyi Guo; Zhiyun Niu; Jingyu Zhang
Journal:  J Physiol Biochem       Date:  2021-01-30       Impact factor: 4.158

Review 2.  A Dormant Microbial Component in the Development of Preeclampsia.

Authors:  Douglas B Kell; Louise C Kenny
Journal:  Front Med (Lausanne)       Date:  2016-11-29

3.  Phosphatidylserine-mediated platelet clearance by endothelium decreases platelet aggregates and procoagulant activity in sepsis.

Authors:  Ruishuang Ma; Rui Xie; Chengyuan Yu; Yu Si; Xiaoming Wu; Lu Zhao; Zhipeng Yao; Shaohong Fang; He Chen; Valerie Novakovic; Chunyan Gao; Junjie Kou; Yayan Bi; Hemant S Thatte; Bo Yu; Shufen Yang; Jin Zhou; Jialan Shi
Journal:  Sci Rep       Date:  2017-07-10       Impact factor: 4.379

4.  A pilot study evaluating changes to haematological and biochemical tests after Flexible Ureterorenoscopy for the treatment of kidney stones.

Authors:  Alyson Jayne Moyes; Rebecca May Lamb; Peter Ella-Tongwiis; Anish Pushkaran; Issam Ahmed; Iqbal Shergill; Stephen Fôn Hughes
Journal:  PLoS One       Date:  2017-07-06       Impact factor: 3.240

5.  Lipopolysaccharide potentiates platelet responses via toll-like receptor 4-stimulated Akt-Erk-PLA2 signalling.

Authors:  Maria E Lopes Pires; Simon R Clarke; Sisi Marcondes; Jonathan M Gibbins
Journal:  PLoS One       Date:  2017-11-14       Impact factor: 3.240

6.  [Progress in quantitative diagnosis of sepsis-induced disseminated intravascular coagulation].

Authors:  L L Luo; H Mei; Y Hu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-05-14

7.  Comparison of a new criteria for sepsis-induced coagulopathy and International Society on Thrombosis and Haemostasis disseminated intravascular coagulation score in critically ill patients with sepsis 3.0: a retrospective study.

Authors:  Renyu Ding; Zhong Wang; Yuan Lin; Baoyan Liu; Zhidan Zhang; Xiaochun Ma
Journal:  Blood Coagul Fibrinolysis       Date:  2018-09       Impact factor: 1.276

8.  Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies.

Authors:  Chrysoula Papageorgiou; Georges Jourdi; Eusebe Adjambri; Amanda Walborn; Priya Patel; Jawed Fareed; Ismail Elalamy; Debra Hoppensteadt; Grigoris T Gerotziafas
Journal:  Clin Appl Thromb Hemost       Date:  2018-10-08       Impact factor: 2.389

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.